PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary

PAVmed

13/08/2026 23:21

PAVmed Inc PAVM.OQ reported a quarterly adjusted loss of 87 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-22.20.  The mean expectation of two analysts for the quarter was for a loss of 47 cents per share. 
Revenue rose 450% to $33.00 thousand from a year ago; analysts expected $48.00 thousand. 
PAVmed Inc's reported EPS for the quarter was a loss of 87 cents​.
The company reported a quarterly loss of $5.48 million.
PAVmed Inc shares had fallen by 29.1% this quarter and lost 36.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 29.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for PAVmed Inc is $36.00, about 86.8% above its last closing price of $4.74
This summary was machine generated from LSEG data August 13 at 10:21 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.47
-0.87
Missed
Mar. 31 2026 
-0.70
-4.42
Missed
Dec. 31 2025 
-5.40
-5.52
Missed
Sep. 30 2025 
-5.10
-8.70
Missed